Nvwm LLC Has $1.29 Million Stake in Synopsys, Inc. (NASDAQ:SNPS)

Nvwm LLC lessened its stake in Synopsys, Inc. (NASDAQ:SNPS) by 3.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,508 shares of the semiconductor company’s stock after selling 94 shares during the quarter. Nvwm LLC’s holdings in Synopsys were worth $1,291,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Keystone Investors PTE Ltd. increased its position in Synopsys by 39.9% during the fourth quarter. Keystone Investors PTE Ltd. now owns 113,581 shares of the semiconductor company’s stock worth $58,484,000 after acquiring an additional 32,383 shares during the period. SeaTown Holdings Pte. Ltd. acquired a new stake in shares of Synopsys during the fourth quarter worth $7,132,000. Moran Wealth Management LLC boosted its holdings in shares of Synopsys by 66.5% during the 4th quarter. Moran Wealth Management LLC now owns 886 shares of the semiconductor company’s stock worth $456,000 after buying an additional 354 shares in the last quarter. Advisor OS LLC bought a new stake in Synopsys in the fourth quarter valued at $220,000. Finally, Massachusetts Financial Services Co. MA increased its position in Synopsys by 6.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,565,534 shares of the semiconductor company’s stock valued at $1,321,019,000 after buying an additional 153,053 shares in the last quarter. 85.47% of the stock is owned by institutional investors.

Insider Transactions at Synopsys

In other news, Director Marc N. Casper bought 750 shares of Synopsys stock in a transaction on Monday, March 25th. The shares were purchased at an average price of $585.45 per share, for a total transaction of $439,087.50. Following the acquisition, the director now owns 1,736 shares of the company’s stock, valued at $1,016,341.20. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Marc N. Casper acquired 750 shares of the firm’s stock in a transaction on Monday, March 25th. The shares were acquired at an average cost of $585.45 per share, for a total transaction of $439,087.50. Following the completion of the transaction, the director now directly owns 1,736 shares in the company, valued at approximately $1,016,341.20. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Sassine Ghazi sold 10,294 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $577.51, for a total value of $5,944,887.94. Following the transaction, the chief executive officer now directly owns 61,863 shares in the company, valued at approximately $35,726,501.13. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,832 shares of company stock worth $15,464,992. 0.66% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Robert W. Baird raised their price objective on shares of Synopsys from $624.00 to $640.00 and gave the company an “outperform” rating in a research note on Thursday, February 22nd. Needham & Company LLC reaffirmed a “buy” rating and set a $660.00 target price on shares of Synopsys in a research report on Friday, March 22nd. Piper Sandler began coverage on shares of Synopsys in a research report on Thursday, April 4th. They set an “overweight” rating and a $665.00 price target for the company. Rosenblatt Securities reaffirmed a “buy” rating and issued a $615.00 price objective on shares of Synopsys in a research report on Thursday, March 21st. Finally, StockNews.com raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Monday, March 18th. Eleven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Synopsys currently has an average rating of “Buy” and an average price target of $601.00.

Synopsys Price Performance

Shares of SNPS traded up $21.65 during midday trading on Wednesday, hitting $581.28. 387,771 shares of the company traded hands, compared to its average volume of 1,156,200. The stock has a 50-day moving average of $557.35 and a 200-day moving average of $542.35. The firm has a market cap of $88.65 billion, a P/E ratio of 63.78, a PEG ratio of 3.26 and a beta of 1.07. Synopsys, Inc. has a one year low of $370.21 and a one year high of $629.38.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, February 21st. The semiconductor company reported $3.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.43 by $0.13. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. Synopsys had a return on equity of 22.88% and a net margin of 22.96%. The firm’s revenue was up 21.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.75 earnings per share. Sell-side analysts forecast that Synopsys, Inc. will post 9.78 EPS for the current fiscal year.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.